Travere Therapeutics (NASDAQ:TVTX) PT Raised to $20.00 at Bank of America
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target raised by Bank of America from $18.00 to $20.00 in a research report sent to investors on Wednesday, Benzinga reports. Bank of America currently has a buy rating on the stock. A number of other brokerages have also recently weighed in on TVTX. Guggenheim raised […]
More Stories
Arctic Star Exploration (CVE:ADD) Trading Down 25% – Here’s What Happened
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) fell 25% on Thursday . The stock traded as low as...
Arctic Star Exploration (CVE:ADD) Trading Down 25% – Here’s What Happened
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) fell 25% on Thursday . The stock traded as low as...
Firethorn Wealth Partners LLC Buys 38 Shares of McDonald’s Co. (NYSE:MCD)
Firethorn Wealth Partners LLC lifted its stake in McDonald’s Co. (NYSE:MCD – Free Report) by 4.5% during the fourth quarter,...
Firethorn Wealth Partners LLC Buys 38 Shares of McDonald’s Co. (NYSE:MCD)
Firethorn Wealth Partners LLC lifted its stake in McDonald’s Co. (NYSE:MCD – Free Report) by 4.5% during the fourth quarter,...
IQE (LON:IQE) Shares Up 17.4% – Here’s Why
IQE plc (LON:IQE – Get Free Report) shares rose 17.4% during mid-day trading on Saturday . The stock traded as...
IQE (LON:IQE) Shares Up 17.4% – Here’s Why
IQE plc (LON:IQE – Get Free Report) shares rose 17.4% during mid-day trading on Saturday . The stock traded as...